193 related articles for article (PubMed ID: 27884763)
21. Mutations in SRD5B1 (AKR1D1), the gene encoding delta(4)-3-oxosteroid 5beta-reductase, in hepatitis and liver failure in infancy.
Lemonde HA; Custard EJ; Bouquet J; Duran M; Overmars H; Scambler PJ; Clayton PT
Gut; 2003 Oct; 52(10):1494-9. PubMed ID: 12970144
[TBL] [Abstract][Full Text] [Related]
22. AKR1D1 and CYP7B1 mutations in patients with inborn errors of bile acid metabolism: Possibly underdiagnosed diseases.
Chen JY; Wu JF; Kimura A; Nittono H; Liou BY; Lee CS; Chen HS; Chiu YC; Ni YH; Peng SS; Lee WT; Tsai IJ; Chang MH; Chen HL
Pediatr Neonatol; 2020 Feb; 61(1):75-83. PubMed ID: 31337596
[TBL] [Abstract][Full Text] [Related]
23. Expression of an estrogen-regulated variant transcript of the peroxisomal branched chain fatty acid oxidase ACOX2 in breast carcinomas.
Bjørklund SS; Kristensen VN; Seiler M; Kumar S; Alnæs GI; Ming Y; Kerrigan J; Naume B; Sachidanandam R; Bhanot G; Børresen-Dale AL; Ganesan S
BMC Cancer; 2015 Jul; 15():524. PubMed ID: 26183823
[TBL] [Abstract][Full Text] [Related]
24. Bile acid synthetic defects and liver disease: a comprehensive review.
Bove KE; Heubi JE; Balistreri WF; Setchell KD
Pediatr Dev Pathol; 2004; 7(4):315-34. PubMed ID: 15383928
[TBL] [Abstract][Full Text] [Related]
25. Infant cholestasis patient with a novel missense mutation in the
Wang HH; Wen FQ; Dai DL; Wang JS; Zhao J; Setchell KD; Shi LN; Zhou SM; Liu SX; Yang QH
World J Gastroenterol; 2018 Sep; 24(35):4086-4092. PubMed ID: 30254413
[TBL] [Abstract][Full Text] [Related]
26. The metabolism of 3alpha, 7alpha, 12alpha-trihydorxy-5beta-cholestan-26-oic acid in two siblings with cholestasis due to intrahepatic bile duct anomalies. An apparent inborn error of cholic acid synthesis.
Hanson RF; Isenberg JN; Williams GC; Hachey D; Szczepanik P; Klein PD; Sharp HL
J Clin Invest; 1975 Sep; 56(3):577-87. PubMed ID: 1159074
[TBL] [Abstract][Full Text] [Related]
27. [Inborn errors of bile acid metabolism].
Stellaard F; Wolthers BG
Tijdschr Kindergeneeskd; 1993 Aug; 61(4):125-34. PubMed ID: 8122223
[TBL] [Abstract][Full Text] [Related]
28. Variable clinical spectrum of the most common inborn error of bile acid metabolism--3beta-hydroxy-Delta 5-C27-steroid dehydrogenase deficiency.
Subramaniam P; Clayton PT; Portmann BC; Mieli-Vergani G; Hadzić N
J Pediatr Gastroenterol Nutr; 2010 Jan; 50(1):61-6. PubMed ID: 19915491
[TBL] [Abstract][Full Text] [Related]
29. Role of peroxisomes in the biosynthesis of bile acids.
Björkhem I; Kase BF; Pedersen JI
Scand J Clin Lab Invest Suppl; 1985; 177():23-31. PubMed ID: 3865345
[TBL] [Abstract][Full Text] [Related]
30. Sodium taurocholate cotransporting polypeptide (SLC10A1) deficiency: conjugated hypercholanemia without a clear clinical phenotype.
Vaz FM; Paulusma CC; Huidekoper H; de Ru M; Lim C; Koster J; Ho-Mok K; Bootsma AH; Groen AK; Schaap FG; Oude Elferink RP; Waterham HR; Wanders RJ
Hepatology; 2015 Jan; 61(1):260-7. PubMed ID: 24867799
[TBL] [Abstract][Full Text] [Related]
31. Molecular genetics of 3beta-hydroxy-Delta5-C27-steroid oxidoreductase deficiency in 16 patients with loss of bile acid synthesis and liver disease.
Cheng JB; Jacquemin E; Gerhardt M; Nazer H; Cresteil D; Heubi JE; Setchell KD; Russell DW
J Clin Endocrinol Metab; 2003 Apr; 88(4):1833-41. PubMed ID: 12679481
[TBL] [Abstract][Full Text] [Related]
32. Lack of 3 beta-hydroxy-delta 5-C27-steroid dehydrogenase/isomerase in fibroblasts from a child with urinary excretion of 3 beta-hydroxy-delta 5-bile acids. A new inborn error of metabolism.
Buchmann MS; Kvittingen EA; Nazer H; Gunasekaran T; Clayton PT; Sjövall J; Björkhem I
J Clin Invest; 1990 Dec; 86(6):2034-7. PubMed ID: 1979336
[TBL] [Abstract][Full Text] [Related]
33. Resolution of liver biopsy alterations in three siblings with bile acid treatment of an inborn error of bile acid metabolism (delta 4-3-oxosteroid 5 beta-reductase deficiency).
Daugherty CC; Setchell KD; Heubi JE; Balistreri WF
Hepatology; 1993 Nov; 18(5):1096-101. PubMed ID: 8225213
[TBL] [Abstract][Full Text] [Related]
34. Inborn errors of metabolism with consequences for bile acid biosynthesis. A minireview.
Björkhem I
Scand J Gastroenterol Suppl; 1994; 204():68-72. PubMed ID: 7824882
[TBL] [Abstract][Full Text] [Related]
35. Peroxisomes and bile acid biosynthesis.
Ferdinandusse S; Houten SM
Biochim Biophys Acta; 2006 Dec; 1763(12):1427-40. PubMed ID: 17034878
[TBL] [Abstract][Full Text] [Related]
36. Bile Acid Synthesis Disorders in Japan: Long-Term Outcome and Chenodeoxycholic Acid Treatment.
Kimura A; Mizuochi T; Takei H; Ohtake A; Mori J; Shinoda K; Hashimoto T; Kasahara M; Togawa T; Murai T; Iida T; Nittono H
Dig Dis Sci; 2021 Nov; 66(11):3885-3892. PubMed ID: 33385262
[TBL] [Abstract][Full Text] [Related]
37. Partial external biliary diversion in bile salt export pump deficiency: Association between outcome and mutation.
Ellinger P; Stindt J; Dröge C; Sattler K; Stross C; Kluge S; Herebian D; Smits SHJ; Burdelski M; Schulz-Jürgensen S; Ballauff A; Schulte Am Esch J; Mayatepek E; Häussinger D; Kubitz R; Schmitt L
World J Gastroenterol; 2017 Aug; 23(29):5295-5303. PubMed ID: 28839429
[TBL] [Abstract][Full Text] [Related]
38. Defective peroxisomal cleavage of the C27-steroid side chain in the cerebro-hepato-renal syndrome of Zellweger.
Kase BF; Björkhem I; Hågå P; Pedersen JI
J Clin Invest; 1985 Feb; 75(2):427-35. PubMed ID: 3973012
[TBL] [Abstract][Full Text] [Related]
39. Development of a system adapted for the diagnosis and evaluation of peroxisomal disorders by measuring bile acid intermediates.
Kawai H; Takashima S; Ohba A; Toyoshi K; Kubota K; Ohnishi H; Shimozawa N
Brain Dev; 2023 Jan; 45(1):58-69. PubMed ID: 36511274
[TBL] [Abstract][Full Text] [Related]
40. Cholic acid therapy in Zellweger spectrum disorders.
Berendse K; Klouwer FC; Koot BG; Kemper EM; Ferdinandusse S; Koelfat KV; Lenicek M; Schaap FG; Waterham HR; Vaz FM; Engelen M; Jansen PL; Wanders RJ; Poll-The BT
J Inherit Metab Dis; 2016 Nov; 39(6):859-868. PubMed ID: 27469511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
